Mar 16, 2022 04:42 AM

China Revises Covid Treatments to Add New Therapies Amid Flare-Up

A makeshift hospital Tuesday in Changchun, Jilin province.
A makeshift hospital Tuesday in Changchun, Jilin province.

China’s national health authorities updated Covid-19 prevention and control guidelines to recommend newly developed treatments and modify quarantine requirements as the country faces its biggest outbreak by far since the early days of the pandemic.

Revised guidelines issued Tuesday by the National Health Commission include the use of Pfizer Inc.’s new Covid-19 pill, the first such a recommendation since the National Medical Products Administration (NMPA) issued conditional approval Feb. 11 of the drug giant’s Paxlovid treatment.

You've accessed an article available only to subscribers
Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
Caixin China Biz Roundup: New ‘Langya’ Virus Detected in China